Osphos®️ (clodronate injection) is approved by the FDA for the control of clinical signs associated with navicular syndrome in horses 4 years and older.

The skeleton of a horse is constantly remodeling, changing and adapting to everyday stresses.

Bisphosphonates like Osphos®️ work on the cellular level within the osteoclast the help control the clinical signs associated with this process.

Osphos®️ is administered as a single intramuscular injection, providing a convenient treatment option with effects observed within a few weeks.

Clinical studies have shown that approximately 65% of horses demonstrated improvement in lameness within 56 days of treatment.